TODD STRATEGY GROUP

Lobbying for VIAL HEALTH TECHNOLOGY, INC. · Vial is a clinical stage biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · California · House · Senate · $90,000.00 income · posted Oct 20, 2025

Lobbying activity 1

Health Issues

New approach methods. FDA Roadmap.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.

Report a problem